Dina Sayed Abdelrahim

Dina Sayed Abdelrahim

Auto-generated profile, based on publicly available information

Dina Sayed Abdelrahim

Department of Clinical Pharmacology, Faculty of Medicine Ain Shams University Cairo Egypt

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 February 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GHGhida Hassan
Ghida Hassan
SKSherif Adel Kamar
Sherif Adel Kamar
HRHagar Yousry Rady
Hagar Yousry Rady
DADina Sayed Abdelrahim
Dina Sayed Abdelrahim
NINesma Hussein Abdel Hay Ibrahim
Nesma Hussein Abdel Hay Ibrahim
NLNoha N. Lasheen
Noha N. Lasheen
Depression is a common stress disability disorder that affects higher mental functions including emotion, cognition, and behavior. It may be mediated by inflammatory cytokines that interfere with neuroendocrine function, and synaptic plasticity. Therefore, reductions in inflammation might contribute to treatment response. The current study aims to evaluate the role of Protein Kinase (PKA)- cAMP response element-binding protein (CREB)- brain derived neurotropic factor (BDNF) signaling pathway in depression and the effects of roflumilast (PDE4 inhibitor) as potential antidepressant on the activity of the PKA-CREB-BDNF signaling pathway, histology, and pro-inflammatory cytokine production. Forty Adult male Wistar rats were divided into 4 groups: Control group, Positive Control group: similar to the controls but received Roflumilast (3 mg / kg / day) by oral gavage for the last 4 weeks of the experiment, Depressed group which were exposed to chronic stress for 6 weeks, and Roflumilast-treated group which were exposed to chronic stress for 6 weeks and treated by Roflumilast (3 mg / kg / day) by oral gavage for the last 4 weeks of the experiment. The depressed group showed significant increase in immobility time with significant decrease in swimming and struggling times, significant decrease in hippocampal PKA, CERB, BDNF, Dopamine, Cortisone, and Superoxide dismutase while hippocampal Phosphodiesterase-E4, Interleukin-6, and Malondialdhyde levels were significantly elevated. These findings were significantly reversed upon Roflumilast treatment. Therefore, it could be concluded that depression is a neurodegenerative inflammatory disease and oxidative stress plays a key role in depression. Roflumilast treatment attenuated the depression behavior in rats denoting its neuroprotective, and anti-inflammatory effects.

Verified
Journal Article
Open access
KEKhalid Elsorady
Khalid Elsorady
LMLamiaa M. Matter
Lamiaa M. Matter
DADina S. Abdelrahim
Dina S. Abdelrahim